Member Info for Chrisatrdg

'Great to have been in Spain with Navantia touring their various facilities, we continue to develop our working relationship in order to take advantage of the many opportunities to collaborate as we move forward #H&W #HarlandandWolff'

http://twitter.com/JohnWoo64494325/status/1220361941539086336

I am moving onto the NASDAQ soon & I am now with Interactive Investors & have just rounded my investment to 51,000 shares by Buying a mere 755 shares as the current SP is cheaper than chips & by being with Interactive Investors once my share certs get added in I can move onto the NASDAQ as Interactive Investors also trade on the NASDAQ.I may add a few more before the close in February. Now showing as Strong Buy

Todays RNS is fantastic news & is a further endorsement of Summits C-Diff drug.I am looking forward to being on the NASDAQ in the next month.

Correction s/be PYC

I am going to stick my neck out & say having looked at the last 12 months accounts & with the expectation of the next 6 months accounts expected in February I believe that we will see a further increase in the SP if the 6 months to 31st December show break even to even a profit if not then certainly later this year.I believe that the company has made good progress in recent times & we can expect a positive future.I recently Bought in a mere 45,000 shares but showing a small loss of £188 but expect this to reverse shortly.When I receive additional funds I will be adding more.GLA

I have now heard back from ii who have asked for the share certificates as soon as possible as they wish to put them back onto AIM using the crest system & they then will go through crest onto the NASDAQ before the close on AIM.I also understand that crest will still exist after delisting on AIM.
I will update after the next move.
I would also like to add:
1) The advice from ii is after they had spoken to their trading dept.
2) I have found Interactive Investors very helpful & I am pleased to have gone with them.

Sareum also think inclusion in the Immuno-oncology article is good as they have tweeted the article this morning:
https://twitter.com/Sareumplc/status/1219547897425027072

Relevant part:
'Cytokines
Cytokines are a bit more complex to explain. In simple terms, they are a group of proteins that play an important part in boosting the immune system.

They have a lot of control over the body’s response to an antigen – a toxin or foreign substance which causes the immune system to start making antibodies.

If there is an imbalance or their production is altered, this can lead to tumours developing.

Scientists have developed man-made versions of interferon and interleukin, which are types of cytokines found in the body.

On the flip side, if the body is producing too many cytokines, Janus Kinase (JAK) inhibitors can stop the proteins from being excessively activated. These have proved useful in treating cancers like renal cell carcinoma and melanoma.

Sareum Holdings PLC (LON:SAR) is among those developing TYK2/JAK1 inhibitors. In fact, it has two of them, SDC-1801 and SDC-1802.

Preclinical programmes have been mapped out for each discovery with the aim of getting them into the clinic in 2020.'

Meet the new investor detailed in todays second RNS

https://www.marketscreener.com/business-leaders/Mahkam-Zanganeh-05T3R9-E/biography/

Immuno-oncology: All you wanted to know but were too afraid to ask:
https://www.proactiveinvestors.co.uk/companies/news/220936/immuno-oncology-all-you-wanted-to-know-but-were-too-afraid-to-ask-220936.html

Zahid Ali Buying in 3.48% as notified last December has there been any further news on his Buy.The SP has dropped since the RNS so is all very quite.Just curious.

I note that the EU match funded project was updated January 2020 see link below:
https://ec.europa.eu/inea/en/connecting-europe-facility/cef-energy/5.1.3-0036-uk-s-m-15

Link to more about the ship:

https://www.stenaline.com/ships/stena-superfast-VII

Iamhappy - I totally agree with your last comment.I am also invested in Summit (SUMM) & suffered a 'train crash' with them failing their DMD Phase 2 trials however they did attend & still do conferences to meet potential investors for their current pipeline & not always a presentation etc.I am happy to wait hopefully something this quarter.

I have taken the plunge again at these low prices but based on my past Buys so far the SP is bound to drop again however now have an extra 50,000 shares at 0.289 cost £144.50 now have in total 2,250,000 at an average of 0.60. With regards where we are I cannot believe that JW buying H&W was of someone who did not know what he was doing so I still have the faith but a little frustrated at being at a loss.

LAST YEARS H&W news & for this year?
'Stena Maintenance Schedule Complete
Tuesday 19 March 2019
Harland and Wolff's Belfast Dock was busy during Quarter 1 2019, starting a sequence of dockings with the arrival of the Stena Lagan on New Year's Eve. Thereafter, in a carefully executed programme to ensure the minimum distruption to sailing schedules and passengers, came the Stena Mersey, Superfast X, Superfast VII and finally the Superfast VIII (see image below).'
Link:
http://www.harland-wolff.com/News/Stena-fleet-maintenance-complete.aspx

We have numerous requests from individuals / organisations looking to provide support for our Marine License Application. Letters of support can be e mailed to:- marinelicensingteam@daera-NI.gov.uk quoting ML28.12 Islandmagee Energy Marine Construction License Application #INFA

Hi PharmaGiles - Thanks for your post & I believe that you are right about the status of your ADD's in your ISA.
I will update when I have had replies from II.

Hi Pharma Giles,

I have just posted the following on ADVFN:

'Hi All I have been having conversations with Summit as well in fact yesterday.
My understanding is that once one has converted back to share certificates it will then be up to your Broker to go through Bank of New York Mellon who hold the ADD'S see details below.
Through the Bank of New York Mellon the UK shares certificates are surrended via your Broker & the shares are then replaced on a 5 for 1 conversion & then we will able to trade on the NASDAQ through our platforms.
At present I have asked Interactive Investors(II) to confirm the route. the guy I spoke to was not sure. I will get an e-mail hopefully soon to let me know the route.
Understand that not all Brokers will work with Mellon but I believe that II will.
I am still waiting for Barclays to complete the process of converting my shares on their platform into share certificate's been a month now & expect it will take a further 2 to 3 weeks to receive my Certificates.The Share Centre took one week.
My aim is to have Summit $ ADD's in a UK Stock ISA & be able to trade on the NASDAQ but any Sells will need to be converted into Sterling before being deposited back into my Stock ISA as cash.
I would also add that the legal basis is that the Companies share capital is always denoted in Ordinary Shares so one can just hold onto them & decide latter to Sell them.
I will keep you all posted.
Details of Bank dealing with Summit ADD's:
Summit Therapeutics
CUSIP: 86627R102
Bank of New York Mellon'

Hi All - I am in the process of converting my online shares into share certificates for which Barclays are still processing my request from last year.Following advice from a Broker I have decided to go with 'Interactive Investor Services Limited (IIS)' at a cost of just under £10 per month plus transaction costs which are not too high.

I was told by the Broker I spoke to this morning that it would be better that I move to a new platform now in order to transfer shares using 'Crest' which will end in February.

IIS trade on the NASDAQ & my account will be able to do this having set it all up including some form of certification in addition I will be putting the shares into a 'Stock ISA'.Any future Sells of my shares will need to be converted into Sterling before the monies are credited to my 'Stock ISA' which can have shares denominated in a foreign currency but not holding US $.

In short I will be able to 'Trade' through an online account my shares in Summit on the NASDAQ likely to be selling not Buying anymore.Regards to all.

I will keep you all posted as it all progress but please do your own research.

#TYK2 in Tumor Immunosurveillance https://mdpi.com/2072-6694/12/1/150… - on referencing Sareum's EORTC'19 poster "The translation of these findings into the clinic would represent an important extension of the use of TYK2inibs in cancer treatment"
Poster link: http://sareum.com/files/5915/7192/3767/TYK2_Poster_EORTC_2019_v2.pdf… $SAR.L
https://twitter.com/Sareumplc/status/1215585823636279296